Lumonus and MSK Advance AI Radiation Planning
SYDNEY, Australia & NEW YORK, United States, April 8, 2026 Lumonus, a healthcare technology company specializing in AI-driven radiation...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SYDNEY, Australia & NEW YORK, United States, April 8, 2026 Lumonus, a healthcare technology company specializing in AI-driven radiation...
SAN ANTONIO, Texas, United States, April 7, 2026 bioAffinity Technologies, Inc. announced that its CyPath® Lung diagnostic test will...
CHICAGO, ILLINOIS, March 23, 2026 GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) has granted...
South San Francisco, California, March 16, 2026 Veracyte, Inc. announced the appointment of Kevin Haas, Ph.D., as Chief Development...
PLEASANTON, CA — March 10, 2026 Veeva Systems announced the acquisition of Ostro, a leading AI-driven brand engagement platform...
Basel, Switzerland — February 20, 2026: Roche announced that the U.S. Food and Drug Administration (FDA) has accepted its...
RESEARCH TRIANGLE PARK, N.C., February 20, 2026 — IQVIA announced continued expansion of its healthcare intelligence and advanced analytics...
LONDON, Oct. 8, 2025 — Haleon, the world’s largest pure-play consumer health company, has partnered with Salesforce to deploy...
